As part of the plan, Amazon has agreed to purchase 100,000 electric delivery vans from vehicle manufacturer Rivian.Technologyread more
Vice President Pence's sit-down with CNBC's Joe Kernen comes as President Donald Trump's White House navigates a forest of thorny political issues.Delivering Alpharead more
The plan will allow Medicare to negotiate lower prices on as many as 250 drugs and apply those discounts to private health plans.Health and Scienceread more
President Donald Trump on Thursday filed a lawsuit against Manhattan District Attorney Cyrus Vance Jr. and his longtime accounting firm Mazars.Politicsread more
Hedge fund titan Leon Cooperman said he's concerned about a shift to the left in the political landscape, which could harm the economy and the stock market.Delivering Alpharead more
Trian Partners co-founder and CEO Nelson Peltz explained to CNBC on Thursday the backstory to his firm's position in struggling General Electric.Delivering Alpharead more
More than half of the patients have been younger than 25 and 16% are younger than 18, CDC principal deputy director Anne Schuchat said.Health and Scienceread more
The Democratic-held House plans to move forward with a bill to fund the government through Nov. 21 and avoid another government shutdown.Politicsread more
Jim Chanos, founder of Kynikos Associates, revealed Thursday a stock he has been shorting for years: kidney dialysis company DaVita.Delivering Alpharead more
GM's usage of temporary workers, potential closure of plants and health care contributions remain major sticking points, according to people familiar with the talks.Autosread more
Here are the biggest calls on Wall Street Tuesday:
"We initiate coverage of Alphabet with a Buy rating and $1,350 price target based on: 1) sum-of-the-parts analysis; 2) estimated YouTube value; and 3) the moat created by GOOGL's Network Effects...We conclude that GOOGL should trade at $1,350 per share in 12 months, which is where we set our price target... If GOOGL were to spin off 10% of its largest 2 or 3 businesses (YouTube, Cloud, etc.) we believe this would unlock significant hidden value while keeping control, accounting consolidation, and 90% of the valuation upside for GOOGL... Importantly, we see valuation downside for the "do nothing" option since FB is GOOGL's single biggest FAANG menace (our view), and FB already has a lower cost of equity..."
"After Tesla's surprise announcement of a sooner than expected $35K Model 3, we noted that it was in many respects Tesla's un-iPhone moment... Much of the bull narrative has rested on Tesla being the next Apple, selling high-volume EVs at premium price point and at high gross margins, in part aided by a unique branded retail presence – a narrative we see as undermined by the recent price cuts and closing of most of the stores... With lower margins not likely to be offset by increased volumes and cost saves, we cut our PT to $192 and remain underweight..."
"We add Buy-rated IR to the Americas Conviction List and increase our 12-month price target to $122 (from $115), representing 15% upside from current levels... Recall we upgraded IR to Buy on 12/7/2017 based on our view that its resilient Climate franchise and accelerating Industrial growth would drive upward EPS revisions and a higher multiple... We acknowledge IR has outperformed over the last 12 months (+20% vs. Multis/S&P -4%/+1%) given its beat-and-raise trajectory and differentiated organic growth/orders... However, our conviction in the call has only strengthened in light of a strong order book exiting 2018, improving price/cost, and a conservative guidance range... We also appreciate IR's exposure to one of our favorite end markets in 2019, HVAC, given ~80% of sales are tied to Climate..."
"We initiate coverage of ACB with an Outperform rating and a C$14 price target... While establishing 20% market share has been an early success story in Canadian adult use cannabis, the company is uniquely positioned to drive leadership in both share and profitability... We are designating ACB as our Top Pick in cannabis, replacing WEED..."
"We are initiating coverage on TSN with an Overweight rating and $78 price target as we think its diversified product offering, best in class operations and prudent capital allocation strategy position the company to create value for shareholders... Additionally, we think shares are trading at an undeserved, discounted valuation currently, providing an attractive entry point for investors to own a company that is well positioned to win in a variety of commodity cycle environments as management executes its strategy to enhance the long-term earnings power of the business..."